Viewing nowFolgazene 5mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Nexfarm Korea Co., Ltd.

MFDS item code 202302482 · Approved 2023.08.22 · Insurance code 662504920
Improvement of blood glucose control in type 2 diabetes; prevention of worsening of chronic heart failure and chronic kidney disease
This medication is used in combination with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It also helps reduce the risk of death and hospitalization due to cardiovascular disease in patients with chronic heart failure. Additionally, it is effective in decreasing the risk of worsening kidney function and cardiovascular mortality in patients with chronic kidney disease. This medication is used alongside standard treatment for each condition and is administered appropriately according to the patient’s condition. In summary, this medication is used for the treatment of type 2 diabetes, chronic heart failure, and chronic kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of antidiabetic drug treatment, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. Swallow the tablet whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. There are no relevant data.
This medication should not be administered to certain patients. Patients allergic to the active ingredient or excipients of this medication, those with type 1 diabetes, diabetic ketoacidosis, lactate intolerance or related genetic diseases, and patients undergoing dialysis should not use this medication. It should be administered with caution to patients with decreased fluid volume or renal function issues. This medication can cause low blood pressure or rapid changes in kidney function, particularly in elderly patients with impaired renal function or those taking diuretics, increasing their risk. Therefore, fluid status and renal function should be assessed prior to administration, and symptoms of hypotension and kidney function should be monitored periodically after administration. This medication is not recommended for patients with severely reduced renal function, and its effect on blood sugar control varies according to renal function. While taking this medication, side effects such as genital infections, urinary tract infections, hypoglycemia, dehydration, and diabetic ketoacidosis may occur. Especially, genital infections are more common in females, with a higher chance of recurrence in those with a history of infections. Hypoglycemia may occur primarily when taken with insulin or sulfonylureas, so dosage adjustments may be necessary when used in combination with these medications. Dehydration or hypotensive symptoms may occur due to decreased fluid volume, so immediate consultation with healthcare professionals is necessary if these symptoms appear. Diabetic ketoacidosis can occur even if blood sugar levels are not high, so if symptoms such as vomiting, abdominal pain, or difficulty breathing occur, immediate examination and treatment are required. This medication is not recommended for patients with severely impaired liver function, and additional caution is needed for elderly patients or those on diuretics. Furthermore, it is advised not to use this medication during pregnancy and to avoid use while breastfeeding. This medication may interact with other drugs, so inform healthcare professionals, especially if you are taking diuretics, insulin, or sulfonylureas. In case of overdose, there is no specific antidote, so treatment should be provided according to the symptoms, and immediate contact with a medical institution is necessary if needed. Finally, the safety and efficacy of this medication have not been established in children and should not be used in pediatric patients. While taking this medication, caution is needed when driving or operating machinery to account for the risk of hypoglycemia. This medication should be stored in a tightly sealed container to prevent exposure to air or moisture and should be kept at room temperature between 1°C and 30°C.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased blood volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, decreased renal creatinine clearance at treatment onset, dyslipidemia, elevated serum creatinine at treatment onset, increased blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric cancer, anaphylactic reaction, chest pain, sensory disturbance, cerebral infarction, nerve compression, sensory loss, headache, dyspepsia, nausea, diarrhea, vomiting, urinary retention, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased appetite, next syndrome, taste disturbance, drowsiness, tension-type headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorder, syncope, tremor, nasopharyngitis, upper respiratory infection, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like symptoms, vaginal discharge, menstrual irregularities, pruritus, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament strain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C.
Yellow, biconvex, round film-coated tablet
Domestic - 30 tablets/bottle, Export - 28 tablets/box [(7 tablets/Alu-Alu) x 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
Nexfarm Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.